NYSE: TMOThermo Fisher Scientific Inc Stock
$546.27+6.34 (+1.17%)
Updated Oct 5, 2022
TMO Price
$546.27
Fair Value Price
N/A
Market Cap
$214.02B
52 Week Low
$497.83
52 Week High
$672.34
P/E
28.83x
P/B
5.06x
P/S
5.02x
PEG
2.3x
Dividend Yield
0.21%
Revenue
$42.82B
Earnings
$7.44B
Gross Margin
46.6%
Operating Margin
20.98%
Profit Margin
17.4%
Debt to Equity
1.14
Operating Cash Flow
$9B
Beta
0.84
Next Earnings
Oct 25, 2022
Ex-Dividend
Sep 14, 2022
Next Dividend
Oct 14, 2022
Zen Score
–
Industry Average (33)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TMO scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TMO ($546.27) is trading below its intrinsic value of $607.90, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TMO is poor value based on its earnings relative to its share price (28.83x), compared to the US market average (28.61x)
P/E vs Market Valuation
TMO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more TMO due diligence checks available for Premium users.
Be the first to know about important TMO news, forecast changes, insider trades & much more!
TMO News
Valuation
TMO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
28.83x
Industry
-82.31x
Market
28.61x
TMO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TMO is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
TMO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.06x
Industry
4.12x
TMO is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TMO price to earnings growth (PEG)
For valuing profitable companies with growth potential
TMO is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
TMO's financial health
Profit margin
Revenue
$11.0B
Net Income
$1.7B
Profit Margin
15.2%
TMO's Earnings (EBIT) of $8.99B... subscribe to Premium to read more.
Interest Coverage Financials
TMO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$90.6B
Liabilities
$48.2B
Debt to equity
1.14
TMO's short-term assets ($18.10B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TMO's long-term liabilities ($37.23B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TMO's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
TMO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$1.5B
Investing
-$419.0M
Financing
-$1.9B
TMO's operating cash flow ($8.84B)... subscribe to Premium to read more.
Debt Coverage Financials
TMO vs Diagnostic & Research Stocks
Thermo Fisher Scientific Stock FAQ
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.